Return On Equity of Viking Therapeutics, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Viking Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • Viking Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -29%, a 130% decline year-over-year.
  • Viking Therapeutics, Inc. annual Return On Equity for 2024 was -12%, a 57% increase from 2023.
  • Viking Therapeutics, Inc. annual Return On Equity for 2023 was -28%, a 35% increase from 2022.
  • Viking Therapeutics, Inc. annual Return On Equity for 2022 was -43%, a 71% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Viking Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -29% -17% -130% 01 Jul 2025 30 Sep 2025
Q2 2025 -20% -5% -33% 01 Apr 2025 30 Jun 2025
Q1 2025 -14% +4% +22% 01 Jan 2025 31 Mar 2025
Q4 2024 -12% +16% +57% 01 Oct 2024 31 Dec 2024
Q3 2024 -13% +19% +59% 01 Jul 2024 30 Sep 2024
Q2 2024 -15% +21% +59% 01 Apr 2024 30 Jun 2024
Q1 2024 -18% +30% +62% 01 Jan 2024 31 Mar 2024
Q4 2023 -28% +15% +35% 01 Oct 2023 31 Dec 2023
Q3 2023 -31% +4% +11% 01 Jul 2023 30 Sep 2023
Q2 2023 -36% -5% -17% 01 Apr 2023 30 Jun 2023
Q1 2023 -49% -21% -75% 01 Jan 2023 31 Mar 2023
Q4 2022 -43% -18% -71% 01 Oct 2022 31 Dec 2022
Q3 2022 -35% -12% -51% 01 Jul 2022 30 Sep 2022
Q2 2022 -31% -10% -50% 01 Apr 2022 30 Jun 2022
Q1 2022 -28% -10% -58% 01 Jan 2022 31 Mar 2022
Q4 2021 -25% -10% -63% 01 Oct 2021 31 Dec 2021
Q3 2021 -23% -10% -72% 01 Jul 2021 30 Sep 2021
Q2 2021 -21% -9% -74% 01 Apr 2021 30 Jun 2021
Q1 2021 -18% -7% -61% 01 Jan 2021 31 Mar 2021
Q4 2020 -15% -6% -70% 01 Oct 2020 31 Dec 2020
Q3 2020 -14% -5% -68% 01 Jul 2020 30 Sep 2020
Q2 2020 -12% -4% -44% 01 Apr 2020 30 Jun 2020
Q1 2020 -11% -2% -21% 01 Jan 2020 31 Mar 2020
Q4 2019 -9% +2% +17% 01 Oct 2019 31 Dec 2019
Q3 2019 -8% +8% +49% 01 Jul 2019 30 Sep 2019
Q2 2019 -8% +27% +77% 01 Apr 2019 30 Jun 2019
Q1 2019 -9% +71% +89% 01 Jan 2019 31 Mar 2019
Q4 2018 -11% 01 Oct 2018 31 Dec 2018
Q3 2018 -16% 01 Jul 2018 30 Sep 2018
Q2 2018 -36% 01 Apr 2018 30 Jun 2018
Q1 2018 -80% 01 Jan 2018 31 Mar 2018

Viking Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -12% +16% +57% 01 Jan 2024 31 Dec 2024
2023 -28% +15% +35% 01 Jan 2023 31 Dec 2023
2022 -43% -18% -71% 01 Jan 2022 31 Dec 2022
2021 -25% -10% -63% 01 Jan 2021 31 Dec 2021
2020 -15% -6% -70% 01 Jan 2020 31 Dec 2020
2019 -9% +2% +17% 01 Jan 2019 31 Dec 2019
2018 -11% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.